Literature DB >> 10581497

Association study of the NF1 gene and autistic disorder.

O Mbarek1, S Marouillat, J Martineau, C Barthélémy, J P Müh, C Andres.   

Abstract

Neurofibromatosis type 1 (NF1) is increased about 150-fold in autistic patients. The aim of this study was to test for an association between the NF1 locus and autistic disorder. The allele distributions of three markers of the NF1 gene were studied in 85 autistic patients and 90 controls. No differences in allele distributions were observed. However, we found a new allele (allele 5) of the GXAlu marker in four autistic patients. Allele 5 was absent in a larger control population (213 individuals). The patients with allele 5 had a more severe clinical picture, mainly in the fields of motility and tonus. Our preliminary results suggest that the NF1 region is not a major susceptibility locus for autism. However, the GXAlu marker of the NF1 gene appears as a possible candidate for a susceptibility locus in a small subgroup of severely affected autistic patients. Am. J. Med. Genet. (Neuropsychiatr. Genet.) 88:729-732, 1999. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  1999        PMID: 10581497

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  19 in total

1.  The parvalbumin/somatostatin ratio is increased in Pten mutant mice and by human PTEN ASD alleles.

Authors:  Daniel Vogt; Kathleen K A Cho; Anthony T Lee; Vikaas S Sohal; John L R Rubenstein
Journal:  Cell Rep       Date:  2015-04-30       Impact factor: 9.423

2.  Gene-class analysis of expression patterns induced by psychoactive pharmaceutical exposure in fathead minnow (Pimephales promelas) indicates induction of neuronal systems.

Authors:  Michael A Thomas; Parag P Joshi; Rebecca D Klaper
Journal:  Comp Biochem Physiol C Toxicol Pharmacol       Date:  2011-06-06       Impact factor: 3.228

3.  Distribution and Within-Family Specificity of Quantitative Autistic Traits in Patients with Neurofibromatosis Type I.

Authors:  John N Constantino; Yi Zhang; Kieran Holzhauer; Sayli Sant; Kyna Long; Alicia Vallorani; Leena Malik; David H Gutmann
Journal:  J Pediatr       Date:  2015-06-04       Impact factor: 4.406

4.  Valosin-containing protein and neurofibromin interact to regulate dendritic spine density.

Authors:  Hsiao-Fang Wang; Yu-Tzu Shih; Chiung-Ya Chen; Hsu-Wen Chao; Ming-Jen Lee; Yi-Ping Hsueh
Journal:  J Clin Invest       Date:  2011-11-21       Impact factor: 14.808

5.  A genomewide screen for autism: strong evidence for linkage to chromosomes 2q, 7q, and 16p.

Authors: 
Journal:  Am J Hum Genet       Date:  2001-07-30       Impact factor: 11.025

6.  Age-related differences in prevalence of autism spectrum disorder symptoms in children and adolescents with Costello syndrome.

Authors:  David D Schwartz; Jennifer M Katzenstein; Eric J Highley; Deborah L Stabley; Katia Sol-Church; Karen W Gripp; Marni E Axelrad
Journal:  Am J Med Genet A       Date:  2017-04-04       Impact factor: 2.802

Review 7.  Autism: in search of susceptibility genes.

Authors:  Janine A Lamb; Jeremy R Parr; Anthony J Bailey; Anthony P Monaco
Journal:  Neuromolecular Med       Date:  2002       Impact factor: 3.843

8.  Neurofibromin is required for barrel formation in the mouse somatosensory cortex.

Authors:  Mark E Lush; Yun Li; Chang-Hyuk Kwon; Jian Chen; Luis F Parada
Journal:  J Neurosci       Date:  2008-02-13       Impact factor: 6.167

9.  Haploinsufficiency for Pten and Serotonin transporter cooperatively influences brain size and social behavior.

Authors:  Damon T Page; Orsolya J Kuti; Chrysa Prestia; Mriganka Sur
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-10       Impact factor: 11.205

10.  Spred1, a negative regulator of Ras-MAPK-ERK, is enriched in CNS germinal zones, dampens NSC proliferation, and maintains ventricular zone structure.

Authors:  Timothy N Phoenix; Sally Temple
Journal:  Genes Dev       Date:  2010-01-01       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.